+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ZIMLAB

Zim Laboratories Share Price

₹111.98 -3.17 (-2.75%)
88.80% Gain from 52W Low

07 Aug, 2026 3:59 PM (IST)

Zim Laboratories live price: ₹111.98. It opened at ₹112 vs previous close ₹115; intraday high/low: ₹115/₹112. The 50 & 200 DMA stand at ₹112.30/₹94.80.

Zim Laboratories Performance

  • Today's Low
  • ₹112
  • Today's High
  • ₹115
  • 52 Week Low
  • ₹59
  • 52 Week High
  • ₹134
  • Open Price₹112
  • Previous Close₹115
  • Volume57,667
  • 50 DMA₹112.30
  • 100 DMA₹103.40
  • 200 DMA₹94.80

Zim Laboratories Chart

Investment Returns

  • Over 1 Month -5.33%
  • Over 3 Month + 8.57%
  • Over 6 Month + 56.22%
  • Over 1 Year + 44.81%

Smart Investing Starts Here Start SIP with Zim Laboratories for Steady Growth!

Invest Now

Zim Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 162.6
  • PEG Ratio
  • -2.7
  • Market Cap Cr
  • 601
  • P/B Ratio
  • 2
  • Average True Range
  • 4.2
  • EPS
  • 0.7
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.1
  • RSI
  • 44.54
  • MFI
  • 40.17

Latest Stock News Updates

Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Please find enclosed the disclosure for the Link of Audio recording of Earnings Call Q1FY27.

Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed the copy of Newspaper Publication for the financial results for the quarter ended 30th June 2026.

Zim Laboratories Ltd - 541400 - Earnings Presentation - Q1 FY27

Please find enclosed the disclosure under Regulation 30 of SEBI LODR Regulations regarding Earnings Presentation for Q1 FY 27

Zim Laboratories Financials

Zim Laboratories Technicals

EMA & SMA

Current Price
₹111.98
-3.17 (-2.75%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹115.20
  • 50 Day
  • ₹112.30
  • 100 Day
  • ₹103.40
  • 200 Day
  • ₹94.80

Resistance and Support

112.93 Pivot Speed
  • R3 117.80
  • R2 116.50
  • R1 114.20
  • S1 110.70
  • S2 109.40
  • S3 107.10

Zim Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-06 Quarterly Results
2026-05-19 Audited Results
2026-02-11 Quarterly Results
2026-01-21 Others
2025-11-12 Quarterly Results
Date Purpose Remarks
2022-12-22 Bonus Bonus issue in the ratio of 2:1 of Rs. 10/-

Zim Laboratories Shareholding Pattern

68.28%
30.36%
1.07%
0.27%
0.03%

About Zim Laboratories

Zim Laboratories is engaged in the manufacturing of formulation drugs and pre formulation ingredients in India and marketing and selling these within and outside India. The Company has wholly owned subsidiaries (ZIM Laboratories FZE,UAE , SIA ZIM Laboratories Limited, Latvia, ZIM Health Technologies Limited, India and ZIM Thinorals Private Limited, India), subsidiary (ZIMTAS PTY Limited, Australia) and stepdown subsidiary (ZIM Scientific Office L.L.C,UAE (the Company and its subsidiaries are together referred to as 'the Group') which are engaged in manufacturing & wholesale of pharmaceutical products, market research and research & development activities. View More
  • NSE Symbol
  • ZIMLAB
  • BSE Symbol
  • 541400
  • ISIN
  • INE518E01015

Similar Stocks to Zim Laboratories

Zim Laboratories FAQs

Zim Laboratories share price is ₹111 As on 09 August, 2026 | 07:29

The Market Cap of Zim Laboratories is ₹600.9 Cr As on 09 August, 2026 | 07:29

The P/E ratio of Zim Laboratories is 162.6 As on 09 August, 2026 | 07:29

The PB ratio of Zim Laboratories is 2 As on 09 August, 2026 | 07:29

The 52 week High & Low of Zim Laboratories is ₹133.9/₹59.3 respectively As on 09 August, 2026 | 07:29

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23